Testing Methodology definition

Testing Methodology has the meaning set forth in Paragraph 12.6.1 of this Settlement Agreement.
View Source
Testing Methodology means the agreed algorithm and methodology, further set out in Exhibit 8, pursuant to which Centogene will perform the Testing Services.
View Source

Examples of Testing Methodology in a sentence

  • As such, SEIU Local 721, DHS and/or DPH shall meet upon request of the Union or Management to address new and/or changes in matters related to employee competency testing, including but not limited to: - Testing Methodology such as written, skills, or other; - Testing Components; - Study methodology including but not limited to study guides and practice skills labs; - Study time and remediation; - Case Presentations (where applicable); and - Corrective responses to test failure.

  • The Public Water System (and all other Persons who are Releasing Persons by virtue of their relationship or association with such Public Water System) will be deemed to give the release set forth in Paragraph 12.1 as to all Claims except those Claims relating to the individual Test Site(s) in which no PFAS at any level was detected in testing under the Testing Methodology.

  • For technology contracts, Company represents, warrants and covenants to use security standards and best practices, including without limitation the OWASP (Open Web Application Security Project), OSSTM (Open Source Security Testing Methodology Manual) and other applicable standards such as the NIST series.

  • Testing Methodology Chromatography linked to Mass Spectrometry Testing Matrix Oral Fluid Target Drugs Drug Cut off Level (Neat Oral Fluid) ng/ml Morphine Codeine Dihydrocodeine 6-monoAcetyl Morphine Cocaine Benzoylecgnine 15 15 15 4 8 8 The laboratory must be able to receive and process oral fluid samples.

  • Testing Methodology Immunoassay – based disposable devices Testing matrix Oral Fluid Target Drugs Drug Cut-off Level (neat oral Fluid) ng/ml Opiates Cocaine/Benzoylecgonine 40 30 Multi-testing panels for cocaine and opiates will be supplied.

  • Testing Methodology Immunoassay – based disposable devices Testing matrix Oral Fluid Target Drugs Drug Cut-off Level (neat oral Fluid) ng/ml Opiates Cocaine / Benzoylecgonine 40 30 Multi-testing panels for cocaine and opiates will be supplied.

  • Testing Methodology Immunoassay – based disposable devices Testing matrix Urine Target Drugs Drug Cut off Level ng/ml Cannabis Opiates Cocaine Amphetamine Methadone Benzodiazapines Buprenorphine 50 300 300 300 300 300 10 Note: Multi testing panels for any combination of drugs and single testing panels will be supplied.

  • Testing Methodology Chromatography linked to Mass Spectrometry Testing Matrix Oral Fluid Target Drugs Drug Cut off Level (Neat Oral Fluid) ng/ml Opiate Morphine Codeine Dihydrocodeine 6-monoAcetyl Morphine Cocaine Cocaine Metabolite 40 40 40 4 8 8 Bidders should demonstrate that the other drugs to be screened for, and the cut off levels proposed, are able to be confirmed by confirmatory analysis The laboratory must be able to receive and process oral fluid samples.

  • Laboratory Testing Methodology The initial testing shall be immunoassay, which meets the requirements of the Food and Drug Administration for commercial distribution.

  • Testers must re-certify every 3 years by: attending a 4-hour Testing Methodology Class completing 24 hours of continuing education annually, this shall be reported to the NDFA office Attending a Testers Workshop (1 workshop in a 3-year period).